Evoke Pharma - 11 Year Stock Split History | EVOK
Stock split history for Evoke Pharma since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| Evoke Pharma Annual Stock Splits |
|---|
| Evoke Pharma Quarterly Stock Splits |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.004B | $0.005B |
| Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.585B | 5.27 |
| Dr Reddy's Laboratories (RDY) | India | $11.835B | 18.71 |
| Aspen Pharmacare (APNHY) | South Africa | $4.900B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.401B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.128B | 2.44 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.004B | 13.71 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.656B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.439B | 0.00 |
| Generation Bio (GBIO) | United States | $0.199B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.074B | 0.00 |
| Personalis (PSNL) | United States | $0.066B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.026B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |